Press Releases

Press Releases

08.29.18
OpGen to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
08.02.18
OpGen Reports Second Quarter 2018 Financial Results And Provides Business Update
07.25.18
OpGen Announces Date of Second Quarter 2018 Financial Results Conference Call
06.14.18
OpGen Modifies Terms of Debt with Merck Global Health Innovation Fund
06.12.18
OpGen Presents Data at ASM Microbe 2018 Demonstrating High Accuracy of Acuitas® for Predicting Antibiotic Resistance in Urine Specimens
06.05.18
OpGen’s Acuitas® AMR Gene Panel u5.47 Data to be Presented at ASM Microbe 2018
05.08.18
OpGen Reports First Quarter 2018 Financial Results and Provides a Business Update
05.01.18
OpGen Announces Date of First Quarter 2018 Financial Results Conference Call
04.24.18
OpGen Highlights Acuitas® Analytical Validation Data for Rapidly Predicting Antibiotic Resistance Using Drug Resistance Gene Profiles at ECCMID
04.19.18
OpGen Completes Rapid Testing Clinical Trial in Colombia and Expands International Operations